Xcellerant Ventures Invests $1M in Geneticure to Advance Precision Medicine and Expand Arizona's Biotech Hub
Precision medicine pioneer to establish new clinical lab in Arizona, bringing predictive testing for renal denervation to market SCOTTSDALE, Ariz., Oct. 21, 2026 /PRNewswire/ -- Xcellerant Ventures today announced a $1 million Fund I investment in Geneticure, a precision medicine pioneer...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.